期刊文献+

不同透析方式对维持血液透析患者微炎症状态的影响 被引量:14

Effect of different hemodialysis ways on microinflammatory state in maintenance hemodialysis patients
下载PDF
导出
摘要 目的研究维持血液透析(maintenance hemodialysis,MHD)患者在不同血液透析方式中,尿素氮(BUN)、血肌酐(SCr)、白蛋白(albumin,Alb)、β2-微球蛋白(β2-microglobulin,β2-MG)、白细胞介素1(interleukin-1,IL-1)、白细胞介素6(IL-6)、C反应蛋白(C-reaction protein,CRP)及降钙素原(procalcitonin,PCT)的浓度变化,了解透析方式对维持血液透析患者微炎症状态的影响。方法选择内蒙古兴安盟人民医院60例MHD患者,男34例,女26例,年龄18-75岁。按透析方式将60例患者分为2组。高通量血液透析(high-flux hemodialysis,HFHD)组32例,使用Fx80聚砜膜进入HFHD;血液灌流(hemoperfusion,HP)联合血液透析(hemodialysis,HD)组28例,使用F6聚砜膜进入HP+HD。在所有患者均接受透析治疗6个月后分别采集2组患者血样检测BUN、SCr、G2-MG、Alb、IL-1、IL-6、CRP及PCT水平,采用方差分析进行比较。结果2组的年龄、性别、透析龄比较,无统计学意义(P〉0.05),具有可比性。高通量血液透析与血液灌流联合血液透析比较,BUN、SCr、Alb水平差异性无统计学意义(P〉0.05);IL-1、IL-6、CRP、PCT、β2-MG水平比较差异性均有统计学意义(P〈0.05)。结论高通量血液透析较血液灌流联合血液透析患者,更好的改善微炎症状态,提高生存质量,而且不会明显增加患者的经济负担。 Objective To investigate the concentration changes of plasma nitrogen (BUN), serum creatinine (SCr), albumin (Alb), β2-microglobulin (β2-MG), interleukin-1 (IL-1), interleukin-6 (IL-6), C-reactive protein (CRP) and Procalcitonin (PCT), and understand the effects of different dialysis ways on microinflammation state in maintenance hemodialysis (MHD) patients. Methods Thirty-two cases undergoing MHD with the using of FxS0 polysulfone were selected as high flux hemodialysis (HFHD) group, and 28 patients with the using of F6 polysulfone served as hemoperfusion combined with hemodialysis patients (HP + HD) group. Blood samples were collected to detect the levels of blood BUN, SCr, β2-MG, IL-1, IL-6, CRP, PCT and Alb. Results There was no significant difference in age, sex, duration of dialysis between two groups (P〉0. 05). There was no significant difference in the changes of BUN, SCr and Alb between two groups (P〉0. 05). There was significant difference in the changes of IL-1, IL-6, CRP, PCT, and β2-MG between two groups. Conclusions As compared with patients undergoing HP + HD, HFHD improves the micro-inflammatory state and quality of life, but does not significantly increase the economic burden on patients.
出处 《临床肾脏病杂志》 2015年第2期106-109,共4页 Journal Of Clinical Nephrology
关键词 高通量血液透析 血液灌流 血液透析 白细胞介素1 白细胞介素6 C反应蛋白 降钙素原 Β2-微球蛋白 High-flux hemodialysis hemoperfnsion hemodialysis IL-1 IL-6 CRP PCT β2-MG
  • 相关文献

参考文献18

  • 1Stenvinkel P, Heimburger 0, J ogestrand T, et al. Strong assonciation between malnutrition, inflammation, and atherosclerosis in chronic renal failure[J]. Kindy Int , 1999, 55 (6): 1899-1911.
  • 2Scboming , Eisenhardt A, Ritz E. The microinflammatory state of uremia[J]. Blood Purif, 2000, 4(16): 327-332.
  • 3Schomig M, Eisenhandt A, Ritz E. The microinflammatory state of uremia[]]. Blood Purif, 2000, 18 (4): 327-332.
  • 4Yeun JY, Levine RA, Mantadilok V, et al. C-reactive protein predicts all-cause and cardiovascular mortailty in hemodialysis patients[J]. Am J kidney Dis, 2000, 35(3): 469-476.
  • 5Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients[J]. Kidney Int , 1999, 52(2): 648-658 .
  • 6Wanner C, Zimemann J, Schwedler S, et al. Inflammation and cardiovascular risk in dialsis patients[J]. Kidney Int , 2002, 61: 99-102.
  • 7Nylen ES, Whang KT, Snider RH, et al. Mortality is increased by procalcitonin and decreased by an antiserum reative to procalcitonin in experimental sepsis [J]. Crit Care Med, 1998, 26(6): 1001-1006.
  • 8Morgenthaler NG, Stuck J, Chancerelle Y, et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection[J]. Horm Metab Res, 2003, 35(5): 290-295.
  • 9Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection[J]. Lancet, 1993, 341(8844): 515-518.
  • 10Meisner M, Tschaikowsky K, Schnabel S, et al. Procalcitonin influence of temperature, storage, anticoagulation and arterial or venous asservatior of blood samples on procalcitonin concentrations[J]. Eur J Clin Chem Biochem, 1997, 35(8): 597- 601.

二级参考文献20

  • 1YoshitioM, Kuhlmann MK, Kotanko P, et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality [J]. J Am Soc Nephrol, 2006, 17: 3510-3519.
  • 2Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: Classification, concentration, and interindividual variability[J]. Kidney Int, 2003, 63:1934- 1943.
  • 3Vanholder R, Meert N, Schepers E, et al. Uremic toxins: Do we know enough to explain uremia[J]. Blood Purif, 2008, 26: 77-81.
  • 4Gejyo F, Yamada T, Odani S, et al. A new form of amyloid protein associated with chronic hemodialysis was identi fled as beta 2 microglobulin[J]. Biochem Biophys Res Commun, 1985, 129:701 -706.
  • 5Bember LM, Jaber BL. Dialysis- ReLated Amyloidosis: Late Finding or Hidden Epidemic[J]. Seminars in Dialysis, 2006, 19:105-109.
  • 6Cheung AK, Rocco MV, gan G, et al. Serum β2- microglobulin levels predict mortality in dialysis patients: results of the HEMO study[J]. J Am Soc Nephrol, 2006, 17:546- 555.
  • 7Okuno S, Ishimura E, Rohno K, et al. Serum β2-microglobulin level is a significant predictor of mortality in mainte nance haemodialysis patients[J]. Nephrol Diat Transplant, 2009, 24: 571-577.
  • 8Nakai S, Iseki K, Tabei K, et al. Outcomes of hermdiafiltration based on Japanese dialysis patient registry[J]. Am J Kidney Disease, 2001, 38: S212-216.
  • 9Furuya R, Kumaqai B, Takahashi M, et al. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients[J]. Blood Purif, 2005,23:311- 316.
  • 10Masakane I. Review: Clinical usefulness of ultrapure diaiysate -recent evidence and perspectives[J]. Ther Apher Dial, 2006, 10: 348-354.

共引文献85

同被引文献110

引证文献14

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部